118 related articles for article (PubMed ID: 34449032)
1. Assessment of the AJCC staging system of pheochromocytomas/paragangliomas.
Abdel-Rahman O
Endocrine; 2022 Jan; 75(1):239-243. PubMed ID: 34449032
[TBL] [Abstract][Full Text] [Related]
2. TNM Staging and Overall Survival in Patients With Pheochromocytoma and Sympathetic Paraganglioma.
Jimenez C; Ma J; Roman Gonzalez A; Varghese J; Zhang M; Perrier N; Habra MA; Graham P; Waguespack SG
J Clin Endocrinol Metab; 2023 Apr; 108(5):1132-1142. PubMed ID: 36433823
[TBL] [Abstract][Full Text] [Related]
3. Revisiting the AJCC staging system of adrenocortical carcinoma.
Abdel-Rahman O
J Endocrinol Invest; 2022 Jan; 45(1):89-94. PubMed ID: 34170487
[TBL] [Abstract][Full Text] [Related]
4. Challenging a dogma; AJCC 8th staging system is not sufficient to predict outcomes of patients with malignant pleural mesothelioma.
Abdel-Rahman O
Lung Cancer; 2017 Nov; 113():128-133. PubMed ID: 29110839
[TBL] [Abstract][Full Text] [Related]
5. Modified the 8th AJCC staging system for patients with advanced prostate cancer: a study based on SEER database.
Sun C; Yang D; Zhu J; Zhou Y; Xiang C; Wu S
BMC Urol; 2022 Nov; 22(1):185. PubMed ID: 36384495
[TBL] [Abstract][Full Text] [Related]
6. Assessment of the external validity of the American Joint Committee on Cancer 8th staging system for anal carcinoma.
Oweira H; Giryes A; Mannhart M; Decker M; Schlumpf R; Abdel-Rahman O
Curr Med Res Opin; 2018 May; 34(5):923-929. PubMed ID: 29448859
[TBL] [Abstract][Full Text] [Related]
7. Assessment of the prognostic value of the 8th AJCC staging system for patients with clinically staged prostate cancer; A time to sub-classify stage IV?
Abdel-Rahman O
PLoS One; 2017; 12(11):e0188450. PubMed ID: 29182656
[TBL] [Abstract][Full Text] [Related]
8. Survival in Papillary Thyroid Microcarcinoma: A Comparative Analysis Between the 7th and 8th Versions of the AJCC/UICC Staging System Based on the SEER Database.
Yang F; Zhong Q; Huang Z; Lian M; Fang J
Front Endocrinol (Lausanne); 2019; 10():10. PubMed ID: 30733707
[No Abstract] [Full Text] [Related]
9. Validation of the AJCC 8th lung cancer staging system among patients with small cell lung cancer.
Abdel-Rahman O
Clin Transl Oncol; 2018 Apr; 20(4):550-556. PubMed ID: 28808860
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the 8th AJCC staging system for pathologically versus clinically staged pancreatic adenocarcinoma: A time to revisit a dogma?
Abdel-Rahman O
Hepatobiliary Pancreat Dis Int; 2018 Feb; 17(1):64-69. PubMed ID: 29428107
[TBL] [Abstract][Full Text] [Related]
11. Modified staging classification for intrahepatic cholangiocarcinoma based on the sixth and seventh editions of the AJCC/UICC TNM staging systems.
Meng ZW; Pan W; Hong HJ; Chen JZ; Chen YL
Medicine (Baltimore); 2017 Aug; 96(34):e7891. PubMed ID: 28834905
[TBL] [Abstract][Full Text] [Related]
12. [Validation and modification of AJCC 8th edition staging system for hepatocellular carcinoma--analysis based on SEER database].
Wei YZ; Huang YQ; Zeng SY; Cai ZB; Peng YH; Zhu CL; Yu WL; Zhou YM
Zhonghua Yi Xue Za Zhi; 2021 Jul; 101(28):2216-2222. PubMed ID: 34333934
[No Abstract] [Full Text] [Related]
13. Validation of the prognostic value of new sub-stages within the AJCC 8th edition of non-small cell lung cancer.
Abdel-Rahman O
Clin Transl Oncol; 2017 Nov; 19(11):1414-1420. PubMed ID: 28497423
[TBL] [Abstract][Full Text] [Related]
14. Retrospective application of the pathologic tumor-node-metastasis classification system for pheochromocytoma and abdominal paraganglioma in a well characterized cohort with long-term follow-up.
Stenman A; Zedenius J; Juhlin CC
Surgery; 2019 Nov; 166(5):901-906. PubMed ID: 31239074
[TBL] [Abstract][Full Text] [Related]
15. Validation of the 8th AJCC staging system for gastric cancer in a population-based setting.
Abdel-Rahman O
Expert Rev Gastroenterol Hepatol; 2018 May; 12(5):525-530. PubMed ID: 29198151
[TBL] [Abstract][Full Text] [Related]
16. Determinants of disease-specific survival in patients with and without metastatic pheochromocytoma and paraganglioma.
Pamporaki C; Prodanov T; Meuter L; Berends AMA; Bechmann N; Constantinescu G; Beuschlein F; Remde H; Januszewicz A; Kerstens MN; Timmers HJLM; Taïeb D; Robledo M; Lenders JWM; Pacak K; Eisenhofer G
Eur J Cancer; 2022 Jul; 169():32-41. PubMed ID: 35500459
[TBL] [Abstract][Full Text] [Related]
17. Validation and modification of staging Systems for Poorly Differentiated Pancreatic Neuroendocrine Carcinoma.
Wang H; Lin Z; Li G; Zhang D; Yu D; Lin Q; Wang J; Zhao Y; Pi G; Zhang T
BMC Cancer; 2020 Mar; 20(1):188. PubMed ID: 32138704
[TBL] [Abstract][Full Text] [Related]
18. Validation of the American Joint Commission on Cancer (AJCC) 8th Edition Staging System for Patients with Pancreatic Adenocarcinoma: A Surveillance, Epidemiology and End Results (SEER) Analysis.
Kamarajah SK; Burns WR; Frankel TL; Cho CS; Nathan H
Ann Surg Oncol; 2017 Jul; 24(7):2023-2030. PubMed ID: 28213792
[TBL] [Abstract][Full Text] [Related]
19. Modification of the 8th American Joint Committee on Cancer staging system for gallbladder carcinoma to improve prognostic precision.
Jiang W; Zhao B; Li Y; Qi D; Wang D
BMC Cancer; 2020 Nov; 20(1):1129. PubMed ID: 33225924
[TBL] [Abstract][Full Text] [Related]
20. Effect of Incorporation of Pretreatment Serum Carcinoembryonic Antigen Levels Into AJCC Staging for Colon Cancer on 5-Year Survival.
Thirunavukarasu P; Talati C; Munjal S; Attwood K; Edge SB; Francescutti V
JAMA Surg; 2015 Aug; 150(8):747-755. PubMed ID: 26083632
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
